Public Pharma for Europe: The case of CAR-T cell therapy

Author: Health Action International

Date: 9/23/2024

Language: English

Learn More: https://www.youtube.com/watch?v=tN24ddAEkxU

You might also enjoy

FINALLY, THE PANDEMIC AGREEMENT!!! …… Many missed opportunities, but a beginning made

‘HIV-ending’ drug could be made for just $25 per patient a year, say researchers

Findings from T1International’s 2024 Out-of-Pocket Expenses and Rationing Survey

Free trade agreement with Malaysia: Switzerland imperils the rights to food and health

Making Access to Quality Healthcare a Top Priority for the EU

Against the normalization of limited access to CAR-T cell therapies